Fulcher Caryl D, Badger Terry, Gunter Ashley K, Marrs Joyce A, Reese Jill M
Department of Advanced Clinical Practice, Duke University Health System, Durham, NC, USA.
Clin J Oncol Nurs. 2008 Feb;12(1):131-40. doi: 10.1188/08.CJON.131-140.
Depression and depressive symptoms are prevalent in people with cancer, yet interventions for depression are a low priority for most oncology care providers. Barriers to diagnosis and treatment include beliefs by patients and providers that depression is an expected correlate of cancer diagnosis, the reluctance of patients to share psychological concerns, and the reticence of some professionals to assess patients with cancer for depressive symptoms in the midst of busy oncology settings. Intervening to diminish depressive symptoms in people with cancer is important because depression has been associated with poorer quality of life, recovery, and possibly survival. This article reviews and summarizes the evidence for pharmacologic and nonpharmacologic interventions for people with cancer and depression and identifies opportunities for future research and practice change.
抑郁症及抑郁症状在癌症患者中很常见，但对于大多数肿瘤护理人员来说，抑郁症的干预并不是首要任务。诊断和治疗的障碍包括患者和医护人员认为抑郁症是癌症诊断的一种预期关联，患者不愿分享心理问题，以及一些专业人员在繁忙的肿瘤治疗环境中不愿对癌症患者进行抑郁症状评估。干预以减轻癌症患者的抑郁症状很重要，因为抑郁症与较差的生活质量、康复情况以及可能的生存率相关。本文回顾并总结了针对癌症合并抑郁症患者的药物和非药物干预的证据，并确定了未来研究和实践变革的机会。
